20 articles
Small trial tests electrical brain stimulation to improve sleep quality and cognitive function in patients with vascular dementia.
A double-blind trial tests whether 810nm photobiomodulation can reverse cognitive impairment in long COVID patients at home.
Study tests VR therapy versus traditional cognitive training in 60 patients with mild cognitive impairment and Alzheimer's disease.
Duke University study tests whether targeted brain stimulation can reverse age-related cognitive decline and improve working memory.
Italian researchers developed a biosensor to track extracellular vesicles in blood, potentially personalizing stroke rehabilitation.
Large 503-patient study tested whether Actovegin could improve thinking and memory problems that persist after stroke recovery.
A Phase 4 RCT tests whether one bevacizumab injection matches two combined doses for neovascular AMD outcomes over 12 months.
A Canadian RCT tests whether virtual aerobic, resistance, and cognitive training can feasibly combat mild cognitive impairment at home.
Novel movement program combining Eastern and Western exercises may help maintain independence and cognitive function in dementia patients.
A Phase II trial tests whether blocking herpes virus activity can protect against Alzheimer's disease in early cognitive decline.
Applied Cognition tests a wearable device that tracks glymphatic function overnight, comparing it to MRI, EEG, and blood biomarkers.
A Phase 1 trial examines whether Botulinum toxin in the glabella and forehead lifts mood and self-appearance satisfaction in returning Botox patients.
Small pilot study tests virtual reality dance intervention for mild cognitive impairment, targeting balance and brain function together.
A pilot RCT tests whether the SysLife© app can reduce subjective stress and improve functioning in work and personal life.
A completed pharmacokinetic study tracks NAD precursors NR and NMN from bloodstream to brain, filling a critical gap in human data.
A 210-person trial tests whether 5-month music therapy programs — and robotic assistants — can slow cognitive decline in older adults.
A completed Mount Sinai RCT tested whether HBOT can improve brain blood flow and cognition in diabetic elders with mild cognitive impairment.
Eight-week mindfulness program tested for women experiencing severe menopause symptoms after preventive ovary removal surgery.
Study tested whether pimavanserin could prevent return of hallucinations and delusions in dementia patients who initially responded to treatment.
A completed pilot trial tests whether 2g/day of a novel carnosine formulation can restore neuromuscular function and quality of life in MS patients.
